COLIA1 Sp1 polymorphism: towards individualized therapy with injected recombinant hGH in GH-deficient adults?

By Koch Christian A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 987-988

Future Medicine

Access to resources Recommend Favorite

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

By Sinués Blanca   Mayayo Esteban   Fanlo Ana   JR Esteban   Bernal María   Bocos Pilar   Bello Elena   Labarta Jose   Ferrández-Longás Angel  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite

Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults

By Hartleb Silke   Plöckinger Ursula   Stalla Günter K   Tuschy Ulrich   Weber Matthias M   Pfützner Andreas   Kann Peter Herbert  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1653-1661

Future Medicine

Access to resources Recommend Favorite

Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults

By Meyer Silke   Haist Marlitt   Schaefer Stephan   Ivan Diana   Ittner Jochen R   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Habbe Nils   Kann Peter H  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1017-1026

Future Medicine

Access to resources Recommend Favorite

The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density

By  

Current Pharmaceutical Design, Vol. 8, Iss. 23, 2002-01 ,pp. : 2023-2032

Bentham Science Publishers

Access to resources Recommend Favorite